|
Volumn 105, Issue 9, 2002, Pages 1122-1127
|
Endogenous ligand of α1 sodium pump, marinobufagenin, is a novel mediator of sodium chloride-dependent hypertension
a a a a a |
Author keywords
Bufadienolides; Hypertension; Na+ K+ exchanging ATPase; Ouabain; Sodium
|
Indexed keywords
ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM);
ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM) INHIBITOR;
DIGITALIS LIKE FACTOR;
LIGAND;
MARINOBUFOGENIN;
SODIUM CHLORIDE;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CONTROLLED STUDY;
ENZYME INHIBITION;
HYPERTENSION;
NATRIURESIS;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
SODIUM EXCRETION;
URINARY EXCRETION;
VASOCONSTRICTION;
ADRENAL GLANDS;
ANIMALS;
ANTIBODIES;
BLOOD PRESSURE;
BUFANOLIDES;
CARDENOLIDES;
DIGOXIN;
ENZYME INHIBITORS;
HYPERTENSION;
LIGANDS;
MALE;
MODELS, ANIMAL;
NA(+)-K(+)-EXCHANGING ATPASE;
NATRIURESIS;
PITUITARY GLAND;
POTASSIUM;
RATS;
RATS, INBRED DAHL;
SAPONINS;
SODIUM;
SODIUM CHLORIDE;
SODIUM CHLORIDE, DIETARY;
VASOCONSTRICTOR AGENTS;
|
EID: 0037022951
PISSN: 00097322
EISSN: None
Source Type: Journal
DOI: 10.1161/hc0902.104710 Document Type: Article |
Times cited : (145)
|
References (23)
|